Seventy-one strains of Serratia marcescens obtained from hospitalized patients of the Instituto Nacional de la Nutricion in Mexico City and two Virginia hospitals (University of Virginia Medical Center and Norfolk General Hospital) were analyzed to find markers useful for the epidemiologic investigation of outbreaks with this organism. Biotyping with commercial microwell systems (API 20E system [Analytab Products, Plainview, N.Y.] and DMS Rapid NFT [DMS Laboratories, Inc., Flemington, N.J.]) was not useful. Biotyping with the system designed by Grimont (assimilation tests, pigment production, and the ability to reduce tetrathionate broth) was helpful to characterize all strains. Of the 37 Mexican strains, 36 belonged to biogroup A 5/8 and 32 were biotype A8b. The 34 strains from the Virginia hospitals were distributed among six different biogroups and 12 biotypes. Significant differences in antimicrobial susceptibility (50% MIC, ,ug/ml) between Mexican and Virginia strains were seen with carbenicillin (256 versus 8), piperacillin (64 versus 4), amikacin (16 versus 2), gentamicin (2 versus 0.5), and tobramycin (16 versus 2). Some Mexican strains showed variability in the susceptibility to amikacin because they were low producers of 6'-N-acetyltransferase type I. The Mexican strains seemed to come from a hospital with cross-infection problems because most were isolated from urine, were multiresistant, and more nonpigmented; in contrast, the strains isolated at University of Virginia Medical Center represent the experience of a hospital with scattered S. marcescens infections. The Grimont biotyping scheme is a useful epidemiologic tool for the clinical microbiologist.
Serratia marcesc ens has become a major etiologic agent of hospital-acquired infections in many countries (1-4, 6, 8, 9, 14-17, 21, 25) , mostly in urologic, acutely ill, and postoperative patients, who develop infections of the urinary tract, bloodstream, lower respiratory tract, and wounds.
To study the epidemiology of such infections, different marker systems of S. inarcescens have been employed such as serotyping, phage typing, bacteriocin production and susceptibility, zymotyping, antibiogram, biochemical typing with commercial microidentification systems such as API 20E, or pattern of assimilation of carbon sources (19, 23, 28) . Bacteriocin typing (20, 26) , biotyping (13, 15) , and phage typing (20) of S. marcescens have shown good correlation with the serotyping system. Specific serotypes, phage types, bacteriocin types, and biotypes of S. inarcescens have been associated with outbreaks of nosocomial infections (9, 15,-20, 25) and with multiresistance (3, 6, 15, 25) .
This study was performed to find a simple typing system which would allow epidemiologic analysis of nosocomial isolates of S. marcescens in the clinical microbiology laboratory. The results of antimicrobial susceptibility testing, production of aminoglycoside-modifying enzymes, biotyping, and serotyping of 71 Confusing results with melibiose and arabinose reactions in the API 20E system required retesting with and without oil overlay. Of 17 strains, 8 with and 4 without oil overlay acidified melibiose, and 5 strains were arabinose positive with and without oil overlay. Oxidation-fermentation tests with arabinose and melibiose were performed in duplicate with the 17 strains; fermentation was negative and oxidation was positive after 72 h of incubation at 35°C. The biotypes obtained with API 20E and DMS Rapid NFT are listed in Table 1 . Seven INN strains assimilated phenylacetate after 3 days of incubation. There were differences in the results of DNase production; at 25°C the strains from INN showed activity after 1.8 ± 0.9 days of incubation, and the strains from Virginia hospitals showed activity after 1.0 ± 0.2 days; at 30°C the INN strains were positive after 1.4 ± 0.6 days, and the Virginia strains were positive after 1 day. At 35°C 25 or 69 strains showed no DNase activity after 24 h.
Biotyping. Thirty-six strains from INN belonged to Grimont biogroup A5/8, and 32 belonged to biotype A8b; the strains from UVA were distributed among six biogroups and 12 biotypes; four of five strains from NOR belonged to biotype A8b (Table 2) . We were able to identify the biogroup in 62 of 71 strains after 4 days of incubation and in 69 of 71 after 7 days. The biotype was identified in 56 of 71 strains after 4 days and in 66 of 71 after 7 days. All strains could be biotyped after 2 weeks of incubation. Statistical differences were observed between the results obtained after incubation for 4 and 14 days (FET, biogroup P < 0.002 and biotype P < 0.0001); and between the results after incubation for 4 and 7 days (FET biogroup P < 0.003 and biotype P < 0.002); a small statistical difference was observed between the biotype results obtained after 7 and 14 days of incubation beta-lactams, aminoglycosides, and trimethoprim-sulfamethoxazole than were the strains from Virginia hospitals, and the INN strains were more susceptible to chloramphenicol.
All of the strains were resistant to ampicillin, cephalothin, and tetracycline. Five of 71 strains were susceptible to cefamandole, and 8 were susceptible to cefoxitin.
There was association between biogroup A5/8 and multiresistance to aminoglycosides, beta-lactams, and trimethoprim-sulfamethoxazole. This phenomenon can be explained by the fact that strains of biogroup A5/8 were isolated mainly at INN. Aminoglycoside-modifying enzymes. The correlation between the production of 6'-N-acetyltransferase type I [AAC(6')-I] and amikacin resistance is shown in Fig. 1 . Two UVA strains and 1 INN strain were determined to be amikacin-susceptible and also high AAC(6')-I producers. After they were subcultured in amikacin-containing medium, amikacin resistance was demonstrated again. Five INN strains produced small amounts of AAC(6')-I, and variable results were observed in the susceptibility tests with four of them. After subculture in medium with amikacin the same variable results were observed in the susceptibility test. From this information the sensitivity of AAC(6')-I testing was calculated to be 80%, the specificity was calculated to be 50%, and the predictive value of a positive test was calculated to be 63%. The correlation between production of 2"-nucleotidyltransferase and gentamicin resistance is shown in Fig. 2 . One INN strain was gentamicin susceptible and a 2"-nucleotidyltransferase producer; the same result was observed even after subculture in medium with gentamicin.
The test sensitivity of 2"-nucleotidyltransferase testing was calculated to be 81%, the specificity was calculated to be 92%, and the predictive value of a positive test was calculated to be 93%. Of Serotyping of unselected strains showed that serotype 014, which had been involved in hospital-acquired infections in many countries (7, 9, 15, 17, 20, 26) , was also represented in our study material. There was an association between biogroup A5/8 and multiresistance patterns (aminoglycosides, beta-lactams, and trimethoprim-sulfamethoxazole). In our material this association was most pronounced in the endemic strains. Other authors (3, 6, 15, 24, 27) also reported an association between specific serotypes, bacteriocin types, and multiresistance.
The majority of our strains was resistant to secondgeneration cephalosporins, although these antibiotics were not in use in Mexico at the time of their isolation. We assume that these strains were naturally resistant to these antibiotics because they are producers of inducible beta-lactamases like those reported by Sanders and Sanders with Enterobacter, PseiidonOntIlts, and Serradtia species (24) .
We observed that some INN strains initially described as amikacin resistant became moderately or fully susceptible to amikacin after several subcultules in medium without antibiotic. Five INN strains showed low production of AAC(6')-I and variability in amikacin susceptibility, four strains remained susceptible even after subculture in medium with amikacin, and one strain was finally identified as partially resistant. This phenomenon may be explained as a result of dilution of the amikacin-resistant population, variability in the expression of the resistance genes, or lack in the affinity of the enzyme produced by these particular strains to the aminoglycoside (5).
The differences in aminoglycoside usage between INN and UVA may explain the level of aminoglycoside resistance. The extensive use of amikacin at INN (G. M. RuizPalacios, J. Sifuentes, and S. Ponce de Leon, Abstr. Intersci. Conf. Antimicrob. Agents Chemother. 943, p. 255, 1984 ) was associated with a decrease of gentamicin resistance in gram-negative rods and the appearance of multiresistant S. mnarcescens strains. During the study period of 32 months, more than 200 S. Inarcesceels strains were isolated from hospitalized patients and outpatients.
Our study of nosocomial S. inarcescens strains from hospitals with endemic and scattered infections indicates that the biotyping system described by Grimont and Grimont (10) , which is also included in the last edition of Bez-ge!'s Manuiial of Systeiadtic BaCteriology (12) , is a useful, reproducible, and reliable tool for epidemiologic studies of S. marcescens. It corresponds well with serotyping and can VOL. 23, 1986 on September 28, 2017 by guest http://jcm.asm.org/ Downloaded from easily and inexpensively be performed in a clinical microbiology laboratory.
